Comprehensive genomic profiling of histologic subtypes of urethral carcinomas
CONCLUSIONS: Comprehensive genomic profiling reveals GA that may be predictive of both targeted and immunotherapy benefit in patients with advanced UrthCa and that could potentially be used in future adjuvant, neoadjuvant, and metastatic disease trials.PMID:34215504 | DOI:10.1016/j.urolonc.2020.12.021
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Joseph Jacob Andrea Necchi Petros Grivas Michael Hughes Thomas Sanford Mehdi Mollapour Oleg Shapiro Ahmad Talal Ethan Sokol Jo-Anne Vergilio Jonathan Killian Douglas Lin Erik Williams Julie Tse Shakti Ramkissoon Eric Severson Amanda Hemmerich Naomi Fergus Source Type: research
More News: Adenocarcinoma | Cancer & Oncology | Carcinoma | Genetics | Immunotherapy | Neoadjuvant Therapy | Urethral Cancer | Urology & Nephrology | Women